(Q46747559)

24 December 2017

title

Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years (English)

1 reference

24 December 2017

author

Irwin Nazareth

series ordinal

3

1 reference

24 December 2017

author name string

Laurence Fardet

series ordinal

1

1 reference

24 December 2017

Irene Petersen

series ordinal

2

1 reference

24 December 2017

publication date

10 March 2011

1 reference

24 December 2017

published in

Rheumatology

1 reference

24 December 2017

volume

50

1 reference

24 December 2017

issue

11

1 reference

24 December 2017

page(s)

1982-1990

1 reference

24 December 2017

The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocortical hormone in arthritis: preliminary report

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Feasibility study and methodology to create a quality-evaluated database of primary care data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

The importance of defining periods of complete mortality reporting for research using automated data from primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

The Read clinical classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Use of oral corticosteroids in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Polymyalgia rheumatica in primary care: a cohort study of the diagnostic criteria and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Is the course of steroid-treated polymyalgia rheumatica more severe in women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Trends in the epidemiology of asthma in England: a national study of 333,294 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Recent trends in physician diagnosed COPD in women and men in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Prevalence of rheumatoid arthritis and rheumatoid factor in women: evidence for a secular decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Polymyalgia rheumatica prevalence in a population-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Validation and validity of diagnoses in the General Practice Research Database: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Validation of The Health Improvement Network (THIN) primary care database for monitoring prescriptions for smoking cessation medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

The cost of glucocorticoid-associated adverse events in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Patients' knowledge of adverse reactions to current medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER017

10.1093/RHEUMATOLOGY/KER017

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017